Matches in SemOpenAlex for { <https://semopenalex.org/work/W4318578637> ?p ?o ?g. }
Showing items 1 to 79 of
79
with 100 items per page.
- W4318578637 endingPage "i265" @default.
- W4318578637 startingPage "i263" @default.
- W4318578637 abstract "Abstract Background miR-16 is important for the inflammatory processes and the signal pathways that participate in the immune system regulation. As there is an immune mucosal inflammation in IBD, miR-16 could also serve as a potential biomarker to assess inflammation. Methods The study aims to assess the expression of serum miR-16 in IBD patients and to correlate its expression with clinical parameters such as disease extent, activity and severity. 35 patients with UC and 35 patients with CD were included in the study. Serum miR-16 expression was assessed with reverse transcriptase quantitative real time PCR (RT-qPCR), and was then correlated with the miR-16 levels in a group of 30 healthy subjects. Results miR-16 expression is increased in patients with CD, localized in the small intestine (3.54±2.33) and in pancolitis Е3 of UC (2.01±1.54). There is a significant difference in miR-16 expression in inflammatory (B1), stenotic (B2) and penetrating (B3) form of CD (р=0.010) with higher expression levels in the more severe B2 and B3 forms. There is no significant difference in miR-16 expression according to the forms of evolution in patients with UC. In patients with CD, there is a moderate direct correlation between the expression of miR-16 and the Crohn’s disease activity index CDAI (r=0.424; p=0.015). miR-16 expression levels increase progressively in correlation with the activity of CD. Patients with moderate activity of their CD have significantly higher miR-16 expression (4.27±3.00) as compared to patients with mild activity (2.38±1.06) or in remission (2.41±1.23) of the disease (р=0.048). The increased expression levels of miR-16 are a risk factor for CDAI > 150 levels (OR=4.80 (0.506-45.495); p=0.015). In patients with UC, there is no correlation between the miR-16 expression levels and the severity (S) index, measured as per the Montreal classification or the endoscopic activity, measured as per the Partial Mayo score. In patients with severe disease, measured by both S index (1.38±0.89) and Partial Mayo score (1.80±1.12), there is a decrease in miR-16, close to normal controls. MiR-16 expression levels do not correlate with any treatment that was given in patients with either CD or UC. Conclusion The increased miR-16 serum expression corelates with the localization of CD in the small intestine and the stenotic and penetrating form of the disease. Increased miR-16 levels are also found in extensive UC. In patients with CD there is a positive correlation between the expression of miR-16 and the activity of the disease as measured by the CDAI." @default.
- W4318578637 created "2023-01-31" @default.
- W4318578637 creator A5015548084 @default.
- W4318578637 creator A5039271482 @default.
- W4318578637 date "2023-01-30" @default.
- W4318578637 modified "2023-10-16" @default.
- W4318578637 title "P101 Circulating MicroRNA-16 in Inflammatory Bowel Disease Patients - Potential Biomarker to Assess Inflammation" @default.
- W4318578637 doi "https://doi.org/10.1093/ecco-jcc/jjac190.0231" @default.
- W4318578637 hasPublicationYear "2023" @default.
- W4318578637 type Work @default.
- W4318578637 citedByCount "0" @default.
- W4318578637 crossrefType "journal-article" @default.
- W4318578637 hasAuthorship W4318578637A5015548084 @default.
- W4318578637 hasAuthorship W4318578637A5039271482 @default.
- W4318578637 hasBestOaLocation W43185786371 @default.
- W4318578637 hasConcept C104317684 @default.
- W4318578637 hasConcept C117220453 @default.
- W4318578637 hasConcept C121608353 @default.
- W4318578637 hasConcept C126322002 @default.
- W4318578637 hasConcept C145059251 @default.
- W4318578637 hasConcept C203014093 @default.
- W4318578637 hasConcept C2524010 @default.
- W4318578637 hasConcept C2776914184 @default.
- W4318578637 hasConcept C2777044582 @default.
- W4318578637 hasConcept C2778260677 @default.
- W4318578637 hasConcept C2778435480 @default.
- W4318578637 hasConcept C2779134260 @default.
- W4318578637 hasConcept C2780479503 @default.
- W4318578637 hasConcept C2781197716 @default.
- W4318578637 hasConcept C33923547 @default.
- W4318578637 hasConcept C48023723 @default.
- W4318578637 hasConcept C526805850 @default.
- W4318578637 hasConcept C55493867 @default.
- W4318578637 hasConcept C71924100 @default.
- W4318578637 hasConcept C86803240 @default.
- W4318578637 hasConcept C8891405 @default.
- W4318578637 hasConcept C90924648 @default.
- W4318578637 hasConceptScore W4318578637C104317684 @default.
- W4318578637 hasConceptScore W4318578637C117220453 @default.
- W4318578637 hasConceptScore W4318578637C121608353 @default.
- W4318578637 hasConceptScore W4318578637C126322002 @default.
- W4318578637 hasConceptScore W4318578637C145059251 @default.
- W4318578637 hasConceptScore W4318578637C203014093 @default.
- W4318578637 hasConceptScore W4318578637C2524010 @default.
- W4318578637 hasConceptScore W4318578637C2776914184 @default.
- W4318578637 hasConceptScore W4318578637C2777044582 @default.
- W4318578637 hasConceptScore W4318578637C2778260677 @default.
- W4318578637 hasConceptScore W4318578637C2778435480 @default.
- W4318578637 hasConceptScore W4318578637C2779134260 @default.
- W4318578637 hasConceptScore W4318578637C2780479503 @default.
- W4318578637 hasConceptScore W4318578637C2781197716 @default.
- W4318578637 hasConceptScore W4318578637C33923547 @default.
- W4318578637 hasConceptScore W4318578637C48023723 @default.
- W4318578637 hasConceptScore W4318578637C526805850 @default.
- W4318578637 hasConceptScore W4318578637C55493867 @default.
- W4318578637 hasConceptScore W4318578637C71924100 @default.
- W4318578637 hasConceptScore W4318578637C86803240 @default.
- W4318578637 hasConceptScore W4318578637C8891405 @default.
- W4318578637 hasConceptScore W4318578637C90924648 @default.
- W4318578637 hasIssue "Supplement_1" @default.
- W4318578637 hasLocation W43185786371 @default.
- W4318578637 hasOpenAccess W4318578637 @default.
- W4318578637 hasPrimaryLocation W43185786371 @default.
- W4318578637 hasRelatedWork W2070285775 @default.
- W4318578637 hasRelatedWork W2137751242 @default.
- W4318578637 hasRelatedWork W2216057689 @default.
- W4318578637 hasRelatedWork W2408939568 @default.
- W4318578637 hasRelatedWork W2418837291 @default.
- W4318578637 hasRelatedWork W2563528523 @default.
- W4318578637 hasRelatedWork W2999879777 @default.
- W4318578637 hasRelatedWork W3187606406 @default.
- W4318578637 hasRelatedWork W4307947091 @default.
- W4318578637 hasRelatedWork W46359855 @default.
- W4318578637 hasVolume "17" @default.
- W4318578637 isParatext "false" @default.
- W4318578637 isRetracted "false" @default.
- W4318578637 workType "article" @default.